Ultrasound-assisted Nasal Bone Fracture Reduction
Development and Application of Musculoskeletal Ultrasound-assisted Visual Reduction Technology for Nasal Bone Fracture**
1 other identifier
interventional
200
1 country
2
Brief Summary
Clinical Trial Abstract Nasal bone fracture is the most common traumatic disease in otorhinolaryngology, which adversely affects nasal appearance and physiological function. Traditional closed reduction relies merely on visual observation and palpation without objective intraoperative evaluation, often leading to insufficient reduction in comminuted, overlapping, or severely swollen fractures and residual nasal deformity. Musculoskeletal ultrasound features real-time dynamic imaging, radiation-free performance, and convenient operation, enabling visualized and precise fracture reduction. However, conventional ultrasound imaging for nasal bones is compromised by air interference due to the protruding nasal structure. This study aims to determine the optimal scanning parameters and suitable coupling agents for high-quality nasal bone imaging by enrolling healthy volunteers and fracture patients. Furthermore, it compares operative duration, postoperative CT scores, and physician and patient satisfaction between traditional reduction and ultrasound-assisted reduction groups. This study intends to establish a standardized intraoperative ultrasound-assisted nasal bone reduction protocol to improve reduction accuracy and clinical satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
September 23, 2026
CompletedFirst Posted
Study publicly available on registry
October 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2029
October 9, 2026
August 1, 2026
6.7 years
September 23, 2026
October 7, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in patient satisfaction with nasal appearance and function assessed by Visual Analogue Scale
Patient satisfaction regarding nasal function and nasal cosmetic appearance measured by Visual Analogue Scale (VAS). VAS ranges from 0 (completely satisfied) to 10 (completely dissatisfied). Outcome is the change from baseline in VAS score.
2 weeks and 3months after surgery
Change in physician-rated nasal appearance assessed by a standardized objective nasal appearance scale
Physician-rated nasal cosmetic appearance assessed by two independent, blinded otolaryngologists using the standardized objective nasal appearance scale. The scale evaluates nasal dorsal alignment, dorsal contour, tip position, nasal symmetry, and overall deformity; each item scores from 0 to 3, total score ranges from 0 to 15, with higher scores indicating greater aesthetic impairment. The outcome is the change from baseline in the total objective appearance score.
2 weeks and 3months after surgery
Study Arms (2)
Ultrasound assist
EXPERIMENTALUltrasound-guided nasal bone fracture reduction
No ultrasound assist
ACTIVE COMPARATORNo ultrasound assists nasal bone fracture reduction
Interventions
Ultrasound-guided nasal bone fracture reduction
No ultrasound-guided nasal bone fracture reduction
Eligibility Criteria
You may qualify if:
- Patients with nasal trauma within 2 weeks, accompanied by nasal deformity or nasal ventilation dysfunction.
You may not qualify if:
- Aged over 70 years or under 5 years, combined with orbital or intracranial injury, or with surgical contraindications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 3100, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2026
First Posted
October 9, 2026
Study Start
January 1, 2023
Primary Completion (Estimated)
September 1, 2029
Study Completion (Estimated)
September 1, 2029
Last Updated
October 9, 2026
Record last verified: 2026-08